|
Index of reports
> Cases with General Physical Health Deterioration ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin where reactions include general physical health deterioration. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Epirubicin side effects in male
Reported by a physician from Poland on 2012-07-24
Patient: male, weighing 77.0 kg (169.4 pounds)
Reactions: Dyspnoea, Pleural Effusion, Palmar-Plantar Erythrodysaesthesia Syndrome, General Physical Health Deterioration, Neutropenia, Polyneuropathy, Disease Progression
Adverse event resulted in: death
Drug(s) suspected as cause:
Epirubicin
Indication: Metastatic Gastric Cancer
Start date: 2010-10-27
End date: 2011-04-06
Capecitabine
Indication: Metastatic Gastric Cancer
Start date: 2010-10-27
End date: 2011-04-06
Oxaliplatin
Indication: Metastatic Gastric Cancer
Start date: 2010-10-27
End date: 2011-04-06
Possible Epirubicin side effects in 63 year old male
Reported by a physician from Poland on 2012-06-27
Patient: 63 year old male
Reactions: Dyspnoea, Palmar-Plantar Erythrodysaesthesia Syndrome, Pleural Effusion, General Physical Health Deterioration, Neutropenia, Polyneuropathy, Disease Progression
Adverse event resulted in: death
Drug(s) suspected as cause:
Oxaliplatin
Indication: Product Used FOR Unknown Indication
Capecitabine
Indication: Product Used FOR Unknown Indication
Epirubicin
Indication: Product Used FOR Unknown Indication
Possible Epirubicin side effects in female
Reported by a physician from Germany on 2012-03-09
Patient: female, weighing 60.0 kg (132.0 pounds)
Reactions: General Physical Health Deterioration, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epirubicin
Dosage: unk
Start date: 2010-02-12
NO Treatment Received
Dosage: not treatment
Cyclophosphamide
Dosage: unk
Start date: 2010-02-12
Docetaxel
Dosage: unk
Start date: 2010-02-12
Other drugs received by patient: Emend; Ciprofloxacin; Granisetron Hydrochloride; Neulasta; Dexamethasone; Mesna
Possible Epirubicin side effects in 43 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-01-16
Patient: 43 year old female, weighing 54.0 kg (118.8 pounds)
Reactions: Dyspnoea, General Physical Health Deterioration, Cardiac Failure Acute, Heart Rate Increased, Ejection Fraction Decreased, Oedema Peripheral, Mitral Valve Incompetence, Pulmonary Congestion, Ventricular Dysfunction, Orthopnoea, Sinus Tachycardia, Atrioventricular Block First Degree
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Trastuzumab
Dosage: 8 mg/kg, unk
Indication: Breast Cancer
Epirubicin
Dosage: 150mg (total dose 750mg)
Indication: Breast Cancer
Trastuzumab
Dosage: 300mg unk
Other drugs received by patient: Cyclophosphamide; Fluorouracil
Possible Epirubicin side effects in 18 year old female
Reported by a individual with unspecified qualification from India on 2011-10-12
Patient: 18 year old female
Reactions: General Physical Health Deterioration, Encephalopathy, Ascites, Weight Increased, Hepatomegaly, Oedema Peripheral, Venoocclusive Liver Disease, Pleural Effusion, Enterococcus Test Positive, Acute Hepatic Failure, Gallbladder Disorder
Drug(s) suspected as cause:
Asparaginase (Asparaginase) (Asparaginase)
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Indication: Acute Lymphocytic Leukaemia
Epirubicin
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
|
